C81.14
Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb
Clinical Classification Guidelines
Medical Intelligence & Overview
Nodular sclerosis Hodgkin lymphoma is a type of lymphatic system cancer that primarily affects lymph nodes, which are part of the immune system. Specifically, the code C81.14 pertains to cases where the disease involves lymph nodes located in the axilla (armpit area) and the upper limbs. This form of Hodgkin lymphoma is characterized by the presence of distinctive nodular formations within the lymph node tissue, often associated with a good prognosis and a relatively favorable response to treatment. Recognized for its typical occurrence in young adults, especially women, this lymphoma subtype is distinguished by its unique cellular structure and clinical behavior.
Causes & Symptoms
Clinical Causes: Genetic factors that influence immune system function Epstein-Barr virus (EBV) infection, which has been linked to some cases A compromised immune system due to HIV/AIDS or immunosuppressive therapy Family history of lymphoma or other lymphatic disorders Environmental exposures, such as certain chemicals or radiation, although evidence remains limited
Key Symptoms: Swollen, painless lymph nodes in the axilla and upper limbs Persistent fatigue and tiredness Unexplained weight loss Fever that comes and goes Night sweats, often drenching clothing and bedding Itching skin Localized pain or discomfort in the affected lymph node regions, especially after alcohol intake General malaise or feelings of discomfort
Diagnostic & Treatment
Diagnosis Path: The diagnosis of nodular sclerosis Hodgkin lymphoma involves a combination of clinical evaluation, imaging, and laboratory tests. Typically, the process includes: - Physical examination to identify swollen lymph nodes - Imaging studies such as CT scans or PET scans to assess the extent of disease - A biopsy of the affected lymph node, where a pathologist examines tissue samples under a microscope to identify characteristic Hodgkin cells and nodular sclerosis features - Blood tests to evaluate overall health and detect signs of lymphoma spread - immunophenotyping and other laboratory analyses to confirm the diagnosis and subtype Understanding the specific location and extent of disease, as indicated by the ICD-10 code, helps guide treatment planning.
Treatment Protocols: Treatment options for nodular sclerosis Hodgkin lymphoma typically combine multiple approaches, tailored to the individual’s disease stage and overall health. Common treatments include: - Chemotherapy, often using regimens such as ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) - Radiation therapy targeted at affected lymph node regions - Immunotherapy treatments, like checkpoint inhibitors, in certain cases - Clinical trials exploring novel therapies and combinations - Supportive care measures to manage side effects and improve quality of life Most cases respond well to these treatments, and many patients can expect favorable long-term outcomes. Follow-up care is essential to monitor for potential recurrence or late effects of treatment.
Clinical Advice & FAQs
Billing Guidance
Is C81.14 a billable ICD-10 code?
Yes, C81.14 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.14?
Clinical documentation must specify the nature of Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
